48
Participants
Start Date
April 30, 2014
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Octreotide
octreotide 100 mcg sc t.i.d. for 4 weeks
ITF2984 500 mcg
ITF2984 500 mcg sc b.i.d for 4 weeks
ITF2984 1000 mcg
ITF2984 1000 mcg sc b.i.d for 4 weeks
ITF2984 2000 mcg
ITF2984 2000 mcg sc b.i.d for 4 weeks
St. Anne University Hospital, Brno
University Hospital Hradec Kralove, Hradec Králové
Université Hôpital Bicêtre, Le Kremlin-Bicêtre
Hôpital de la TIMONE, Marseille
Az MH Honvédkórház, Budapest
Semmelweis University, Budapest
University of Pecs, Pécs
University of Szeged, Szeged
Presidio Ospedaliero di Montichiari, Brescia
Policlinico G. Martino, Messina
Fondazione Policlinico IRCCS, Milan
IRCCS Ospedale San Raffaele, Milan
Università Federico II, Napoli
Università di Pisa, Pisa
San Giovanni Battista Molinette, Torino
Leiden University Medical Center, Leiden
Erasmus Medisch Centrum, Rotterdam
University Children's Hospital of Cracow, Krakow
Klinika Endokrynologii Centrum Medycznego Kształcenia Podyplomowego, Warsaw
Samodzielny Publiczny Szpital Kliniczny, Wroclaw
Institutul de Endocrinologie C.I.Parhon, Sectia clinica de endocrinologie II, Bucharest
Institutul de Endocrinologie C.I.Parhon, Sectia clinica de endocrinologie I, Bucharest
Institutul de Endocrinologie C.I.Parhon, Sectia clinica de endocrinologie VI, Bucharest
Clinical Center of Serbia, Belgrade
Clinical center of Nis, Niš
Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela
Lead Sponsor
Italfarmaco
INDUSTRY